Clinical Trial Update: Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Noex 32µg to Budecort Aqua 32µg for allergic rhinitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Budecort Aqua® 32µg
• Noex® 32µg

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: WITHDRAWN